Skip to main content
Top

30-09-2020 | EASD 2020 | Conference coverage | Article

DAPA-CKD: Does confirmed renoprotection make the case for first-line SGLT2 inhibition?

print
PRINT
insite
SEARCH

Luigi Gnudi reflects on what the findings of DAPA-CKD mean for diabetologists, nephrologists, and treatment guidelines (6:10).

Read the transcript

print
PRINT

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »